tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Seamus Fernandez, 30 are a HOLD (17.75%), 139 are a BUY (82.25%).
Analyst Seamus Fernandez, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 47.72% that have a potential upside of 39.14% achieved within 338 days.
Seamus Fernandez’s has documented 313 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ARQT, Arcutis Biotherapeutics at 27-Feb-2026.
Analyst best performing recommendations are on ADGI (ADAGIO THERAPEUTICS).
The best stock recommendation documented was for ITCI (INTRACELLULAR TH) at 9/28/2016. The price target of $29 was fulfilled within 1 day with a profit of $13.35 (31.52%) receiving and performance score of 315.23.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 21-Apr-2020
$193
$-0.02 (-0.01%)
$178
5 years 10 months 8 days ago
(21-Apr-2020)
2/8 (25%)
$8.96 (4.87%)
125
Buy
$203
6 years 11 days ago
(18-Feb-2020)
1/2 (50%)
$20.22 (11.61%)
95
Hold Since 30-Jan-2019
$203
$9.98 (5.17%)
$178
6 years 19 days ago
(10-Feb-2020)
5/16 (31.25%)
$4.87 (2.46%)
74
Hold Since 22-Jan-2020
$188
6 years 1 months 7 days ago
(22-Jan-2020)
2/11 (18.18%)
$50.95 (37.18%)
254
Hold Since 19-Nov-2019
$200
6 years 3 months 10 days ago
(19-Nov-2019)
2/11 (18.18%)
$73.92 (58.63%)
290
Which stock is Seamus Fernandez is most bullish on?
Which stock is Seamus Fernandez is most reserved on?
What Year was the first public recommendation made by Seamus Fernandez?
